| Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance SS Harun Patel, Rahul Pawara, Azim Ansari European Journal of Medicinal Chemistry 142, 32-47, 2017 | 150 | 2017 |
| Computational identification of 2, 4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free … R Pawara, I Ahmad, S Surana, H Patel In Silico Pharmacology 9, 1-22, 2021 | 46 | 2021 |
| The repurposed ACE2 inhibitors: SARS-CoV-2 entry blockers of Covid-19 I Ahmad, R Pawara, S Surana, H Patel Topics in Current Chemistry 379, 1-49, 2021 | 45 | 2021 |
| Design and Synthesis of Quinazolinones as EGFR inhibitors to Overcome EGFR Resistance Obstacle HM Patel, R Pawara, A Ansari, M Noolvi, S Surana Bioorganic & Medicinal Chemistry 25 (10), 2713-2723, 2017 | 45 | 2017 |
| A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity H Patel, R Pawara, K Pawara, F Ahmed, A Shirkhedkar, S Surana Tuberculosis 117, 79-84, 2019 | 41 | 2019 |
| Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC) R Pawara, I Ahmad, D Nayak, S Wagh, A Wadkar, A Ansari, S Belamkar, ... Bioorganic Chemistry 115, 105234, 2021 | 40 | 2021 |
| In silico search of triple mutant T790M/C797S allosteric inhibitors to conquer acquired resistance problem in non-small cell lung cancer (NSCLC): a combined … HM Patel, I Ahmad, R Pawara, M Shaikh, S Surana Journal of Biomolecular Structure and Dynamics 39 (4), 1491-1505, 2021 | 40 | 2021 |
| Synthesis, molecular modeling study, and quantum-chemical-based investigations of isoindoline-1, 3-diones as antimycobacterial agents I Ahmad, RH Pawara, RT Girase, AY Pathan, VR Jagatap, N Desai, ... ACS omega 7 (25), 21820-21844, 2022 | 37 | 2022 |
| Synthesis, molecular modelling study of the methaqualone analogues as anti-convulsant agent with improved cognition activity and minimized neurotoxicity I Ahmad, SR Akand, M Shaikh, R Pawara, SN Manjula, H Patel Journal of Molecular Structure 1251, 131972, 2022 | 34 | 2022 |
| Emerging approaches to overcome acquired drug resistance obstacles to osimertinib in non-small-cell lung cancer M Shaikh, Y Shinde, R Pawara, M Noolvi, S Surana, I Ahmad, H Patel Journal of Medicinal Chemistry 65 (2), 1008-1046, 2021 | 34 | 2021 |
| Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach HP R. Girase, I. Ahmad, R. Pawara SAR and QSAR in Environmental Research, 2022 | 30 | 2022 |
| Investigating the Impact of Different Acrylamide (Electrophilic Warhead) on Osimertinib's Pharmacological Spectrum by Molecular Mechanic and Quantum Mechanic Approach SS Harun Patel, Iqrar Ahmad, Harsha Jadhav, Rahul Pawara, Deepak Lokwani Combinatorial Chemistry & High Throughput Screening 25 (1), 149-166(18), 2022 | 29 | 2022 |
| Pyridine and nitro-phenyl linked 1, 3, 4-thiadiazoles as MDR-TB inhibitors H Patel, H Jadhav, I Ansari, R Pawara, S Surana European Journal of Medicinal Chemistry 167, 1-9, 2019 | 24 | 2019 |
| Design and synthesis of novel 2, 4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors H Patel, A Ansari, R Pawara, I Ansari, H Jadhav, S Surana Journal of Receptors and Signal Transduction 38 (5-6), 393-412, 2018 | 23 | 2018 |
| In-silico evidences for binding of Glucokinase activators to EGFR C797S to overcome EGFR resistance obstacle with mutant-selective allosteric inhibition H Patel, R Pawara, S Surana Computational biology and chemistry 74, 167-189, 2018 | 23 | 2018 |
| Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC) R Pawara, I Ahmad, D Nayak, S Belamkar, S Surana, CN Kundu, C Patil, ... Journal of Molecular Structure 1254, 132313, 2022 | 18 | 2022 |
| In silico toxicity investigation of Methaqualone’s conjunctival, retinal, and gastrointestinal hemorrhage by molecular modelling approach I Ahmad, R Pawara, H Patel Molecular Simulation 48 (18), 1639-1649, 2022 | 17 | 2022 |
| Exploring the anti-breast cancer potential of flavonoid analogs V Thakor, M Poddar, S Dey, SN Manjula, SRV Madhunapantula, ... RSC advances 6 (82), 79166-79179, 2016 | 15 | 2016 |
| Triazolopyridine, a leitmotif of synthetic methods and pharmacological attributes: An extensive review IA Popat Mohite, Deepali Nahar, Rahul Pawara, Taha Alqahtani, Sayed M. Eldin ... Arabian Journal of Chemistry 16 (10), 105181, 2023 | 4 | 2023 |
| Third Generation EGFR Inhibitors: Overcoming EGFR Resistance and Toxicity Problems HM Patel, R Pawara, SJ Surana Elsevier, 2018 | 4 | 2018 |
